Safety and Clinical Outcomes of Pembrolizumab Standard-Interval Dosing Versus Extended-Interval Dosing in Patients with Breast Cancer
Related Posts
Wang Y, Sun B, Ma F, Tao B, Gu Y, Zhou Z, Kim J, Zhang L, Liu Z, Ten Hoeve J, Stiles L, Fernandez-Del-Rio L,[...]
Denorme F, Portier I, Castro H, Ajanel A, Kosaka Y, Benzon H, De Araujo CV, Souvenir R, Abel ED, Weyrich AS, Rondina MT, Campbell RA.[...]
Braunstein GD, Gindi EM, Kanani DJ, Brien E, Matcuk GR Jr, Obeidin F. Gluteal hemangioma mimicking a neuroendocrine tumor: pitfalls in neuroendocrine tumor diagnostic testing.[...]